In this special 50th episode of Believe in Progress, host Mitch Stoller, chief philanthropic officer of the AACR, discusses the origins of the podcast, the guests so far, and what is next.
Listen and SubscribeCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe AACR Cancer Progress Report highlights research-driven advances against the collection of devastating diseases we call cancer.
Read the ReportMore than 13,500 adults in the U.S. are expected to be diagnosed with soft tissue sarcomas this year. July is Sarcoma and Bone Cancer Awareness Month. Learn more about these cancers.
Learn MoreFrom April through June, the U.S. FDA issued 13 new oncology approvals, expanding treatment options for patients with cancer.
Read the AACR BlogAs people with advanced disease live longer, they face physical and mental health side effects. Patient advocates say research and care must focus on their unique needs.
Read Practical KnowledgeWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe official news website of the AACR Annual Meeting 2025. Stay up to date on the latest developments from the most important cancer meeting in the world.
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More